Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogs possessing cyclic amino acid residues at the C-terminal position
- 1 October 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 29 (10) , 2100-2104
- https://doi.org/10.1021/jm00160a051
Abstract
The synthesis of several analogues of L-proly-L-leucylglycinamide (PLG) was carried out in which the glycinamide residue was replaced with the following cyclic amino acid residues: L- and D-prolinamide, (+)- and(-)-thiazolidine-2-carboxamide, L- and D-3,4-dehydroprolinamide, L-azetidine-2-carboxamide, L-piperidine-2-carboxamide, and L-thiazolidine-4-carboxamide to give PLG analogues 2-10, respectively. The ability of these analogues to enhance the binding of the dopamine agonist ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) to dopamine receptors was determined by using bovine brain tissue. All of the PLG analogues synthesized in this study enhanced the binding of ADTN to central dopamine receptors. The percent enhancement of ADTN binding produced by analogues 2, 3, and 7-10 at various concentrations was comparable to the percent enhancement produce by PLG. The PLG analogues Pro-Leu-(+)-thiazoidine-2-carboxamide (4), Pro-Leu-(-)-thiazoidine-2-carboxamide (5), and Pro-Leu-L-3,4-dehydroprolinamide (6), however, produced significantly greater enhancement (2-3-fold) in ADTN binding than did PLG.This publication has 12 references indexed in Scilit:
- Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to ratsNeuropharmacology, 1984
- Binding studies of L-Prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brainPharmacological Research Communications, 1983
- The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned ratsGeneral Pharmacology: The Vascular System, 1982
- CNS putative L-prolyl-L-leucyl-glycinamide (PLG) receptors, brain and lymphocyte dopamine receptorsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Neuroleptic Drug-Induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-Leucyl-GlycinamideScience, 1981
- The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the ratLife Sciences, 1981
- Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindingsPeptides, 1981
- Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amidePharmacology Biochemistry and Behavior, 1978
- Study of the structural requirements for Dopa potentiation and oxotremorine antagonism by L-prolyl-L-leucylglycinamideJournal of Medicinal Chemistry, 1978
- SYNTHESIS, BIOLOGICAL ACTIVITY, AND TRITIATION OF L‐3, 4‐DEHYDROPROLINE‐CONTAINING PEPTIDESInternational Journal of Peptide and Protein Research, 1977